Literature DB >> 7797936

Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system.

J Rydberg1, H Miörner, A Chandramuki, M Lantz.   

Abstract

Distributions of tumor necrosis factor (TNF) and its soluble receptor forms, R55-BP and R75-BP, were analyzed in the cerebrospinal fluid of patients with severe acute or chronic central nervous system infections. Tuberculous infections were associated with high ratios of R55-BP and R75-BP to TNF, 27.2 and 28.0, respectively, suggesting a small biologically active fraction of TNF. The opposite was found in subjects with acute bacterial meningitis. They had large fractions of biologically active TNF and thus low ratios of R55-BP and R75-BP to TNF, 3.7 and 4.0, respectively. It is hypothesized that chronic infectious diseases, such as tuberculous infections, may be associated with inadequate production of TNF and a concomitant relative increase of soluble TNF receptors, which may prolong the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797936     DOI: 10.1093/infdis/172.1.301

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

2.  Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis.

Authors:  C M Mastroianni; L Lancella; F Mengoni; M Lichtner; P Santopadre; C D'Agostino; F Ticca; V Vullo
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

3.  Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells.

Authors:  Marlynne Q Nicol; Jean-Marie Mathys; Albertina Pereira; Kevin Ollington; Michael H Ieong; Paul R Skolnik
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.